Role of Cannabinoids in Chronic Pain Management: A Pharmacological Review

Authors

  • Shashi Saxena Assistant Professor of Mahadeva Lal Schroff College of Pharmacy Aurangabad, Bihar
  • Kaju Kumari Students of Mahadeva Lal Schroff College of Pharmacy Aurangabad, Bihar
  • Narendra Kumar Paswan Students of Mahadeva Lal Schroff College of Pharmacy Aurangabad, Bihar
  • Pankaj Kumar Students of Mahadeva Lal Schroff College of Pharmacy Aurangabad, Bihar

DOI:

https://doi.org/10.32553/jbpr.v15i3.1511

Keywords:

Cannabinoids

Abstract

Chronic pain is a multifactorial condition with significant physical, emotional, and socioeconomic burdens. Conventional analgesics, including opioids and non-steroidal anti-inflammatory drugs (NSAIDs), often fail to provide sustained relief and are associated with adverse effects, including tolerance, dependence, and gastrointestinal complications. In recent years, cannabinoids—bioactive compounds derived from the Cannabis sativa plant—have emerged as promising alternatives or adjuncts in chronic pain management due to their interaction with the endocannabinoid system (ECS). This system, which plays a crucial role in modulating pain perception, is influenced by both Phyto cannabinoids and synthetic cannabinoids, particularly Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). This pharmacological review explores the mechanisms through which cannabinoids modulate pain, their pharmacokinetics and pharmacodynamics, clinical efficacy in various chronic pain conditions (neuropathic, inflammatory, cancer-related), and safety profiles. It also examines the legal and regulatory challenges associated with medical cannabis, especially within the Indian context. The report highlights the limitations in existing clinical trials, emphasizing the need for more extensive and standardized studies to support evidence-based use. Moreover, advances in cannabinoid formulation and delivery systems are discussed as they aim to enhance bioavailability and therapeutic outcomes.

The review concludes that while cannabinoids show significant potential in chronic pain management, their clinical application requires a nuanced understanding of their pharmacology, patient variability, and a robust regulatory framework. A multidisciplinary approach incorporating personalized medicine may pave the way for their integration into mainstream pain management strategies.

Keywords: Cannabinoids, Chronic Pain, Endocannabinoid System, Δ9-THC, CBD, Neuropathic Pain, Medical Cannabis, Pharmacological Review, Pain Management, Analgesics.

 

Downloads

Published

2026-06-24

How to Cite

Saxena, S. ., Kumari, K. ., Paswan, N. K. ., & Kumar, P. . (2026). Role of Cannabinoids in Chronic Pain Management: A Pharmacological Review. Journal of Biomedical and Pharmaceutical Research, 15(3), 264–274. https://doi.org/10.32553/jbpr.v15i3.1511

Issue

Section

Articles